Google has invested in the largest private testing company, American 23andMe. The company has already sequenced more than one million people, both Americans and other nationalities. "After all, it is no coincidence that Google has acquired this company, I suppose," comments Bjørn Erik Thon of the Data Inspectorate. Google already sells advertising space tailored to people's search and online history. Can we imagine that in the future Google will show us targeted advertising for drugs based on our genes?
Taking advantage of people's health anxiety. There is great skepticism in the health service about this type of self-test, according to Cathrine Bjorvatn. Bjorvatn is a researcher and genetic supervisor at Haukeland. . .
To continue reading, create a new free reader account with your email,
or logg inn if you have done it before. (click on forgotten password if you have not received it by email already).
Select if necessary Subscription (69kr)